Positive effect of alendronate on bone mineral density and markers of bone turnover in patients with rheumatoid arthritis on chronic treatment with low-dose prednisone: A randomized, double-blind, placebo-controlled trial

Osteoporosis International

Volumn 17, Issue 5, 2006, Pages 716-723

  Lems, W F ^a,b   Lodder, M C ^a   Lips, P ^a   Bijlsma, J W J ^c   Geusens, P ^d,e   Schrameijer, N ^f   Van De Ven, C M ^f   Dijkmans, B A C ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SLOTERVAART HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HASSELT UNIVERSITY   (Belgium)

^f MSD Agvet   (Netherlands)

Author keywords

Alendronate; Bone mineral density; Prednisone; Rheumatoid arthritis

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; AMINO TERMINAL TELOPEPTIDE; CALCIUM; COLECALCIFEROL; PLACEBO; PREDNISONE;

ADULT; AGE DISTRIBUTION; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE TURNOVER; CALCIUM INTAKE; CARDIOTOXICITY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG INDUCED CANCER; DYSPEPSIA; ELBOW FRACTURE; FEMALE; GASTROENTERITIS; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HIP; HUMAN; INFECTION; LONG TERM CARE; LOW DRUG DOSE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SPINE RADIOGRAPHY; STATISTICAL SIGNIFICANCE; STOMATITIS; THORACIC SPINE; TIBIA FRACTURE; ULCER; URINARY EXCRETION; VERTEBRA FRACTURE; VERTEBRA MALFORMATION; WRIST FRACTURE;

ABSORPTIOMETRY, PHOTON; ALENDRONATE; ALKALINE PHOSPHATASE; ANALYSIS OF VARIANCE; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; COLLAGEN TYPE I; DENSITOMETRY, X-RAY; DOUBLE-BLIND METHOD; FEMALE; GLUCOCORTICOIDS; HIP; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; PEPTIDES; PREDNISONE;

EID: 33645798131     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-005-0037-2     Document Type: Article

References (22)

1. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Int Med 112:352-364
2. Staa TP van, Leufkens HGM, Abenhaim L et al (2002) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:1993-2000
3. Manologas SC, Weinstein RS (1999) New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14:1061-1066
4. Canalis E (2003) Mechanisms of glucocorticoid-induced osteoporosis. Curr Opinion Rheumatol 15:454-457
5. Haugeberg G, Orstavik R, Kvien TK (2003) Effects of rheumatoid arthritis on bone. Curr Opinion Rheumatol 15:469-475
6. Bijlsma JW, Everdingen AA van, Huisman M et al. (2002) Glucocorticoids in rheumatoid arthritis: effects on erosions and bone. Ann NY Acad Sci 966:82-90
7. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S et al (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. New Engl J Med 334:292-299
8. Cohen S, Levy RM, Keller M, Boling E, Emkey RD, Greenwald M et al (1999) Risedronate therapy prevents corticosteroid-induced bone loss. Arthritis Rheum 42:2309-2318
9. Adachi JD, Saag KG, Delmas PD, Liberman UA, Emkey RD, Seeman E et al (2001) Two-year effects of alendronate on bone mineral density and vertebral fracture rate in patients receiving glucocorticoids. Arthritis Rheum 44:200-211
10. Wallach S, Cohen S, Reid DM, Hughes RA, Hosking DJ, Laan RF et al (2000) Effects of risedronate treatment on bone density and vertebral fracture rate in patients with corticosteroid therapy. Calcif Tissue Int 67:277-285
11. Arnett FC, Edworthy SM, Bloch DA, Mc Shane DJ, Fries JR, Cooper NS et al (1998) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
12. Genant HK, Jergas M, Palermo et al (1996) Comparison of semiquantitative techniques and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis. J Bone Miner Res 11:984-996
13. Homik JE, Cranney A, Shea B, Tugwell P, Wells G, Adachi JD, et al (1999) A meta-analysis on the use of bisphosphonates in corticosteroid-induced osteoporosis. J Rheumatol 26:1148-1157
14. American College of Rheumatology AdHoc Committee on Glucocorticoid- Induced Osteoporosis 2001 (2001) Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 44:1496-1503
15. Amin S, Lavalley MP, Simms RW, Felson DT (2002) The comparative efficacy for the management of corticosteroid-induced osteoporosis: a meta regression. J Bone Miner Res 17:1512-1516
16. Kirwan JR (1995) The Arthritis and Rheumatism Council low dose glucocorticoid study group. The effects of glucocorticoids on joint destruction in rheumatoid arthritis. N Engl J Med 333:142-146
17. Everdingen AA van, Jacobs JWJ, Siewertz van Reesema DR et al (2002) Low dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease modifying properties and side effects: a randomized, double blind, placebo-controlled trial. Ann Int Med 136:1-12
18. Bijlsma JWJ, Boers M, Saag KG, Furst DE (2003) Glucocorticoids in the treatment of early and late RA. Ann Rheum Dis 62:1033-1037
19. Buckley LM, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemare S et al (1996) Calcium and vitamin D supplementation prevents bone loss in patients with rheumatoid arthritis: a randomized, double blind placebo controlled trial. Ann Int Med 125:961-966
20. Cranney A, Wells G, Willan A, Griffith L, Zytaruk N, Robinson et al. (2002) Alendronate. Meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 23:508-516
21. Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, Lacroix AZ et al (2002) Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112:281-289
22. Ross PD, Davis JW, Epstein RS, Wasnich RD (1991) Preexisting fractures and bone mass predict vertebral fracture incidence in women. Ann Int Med 114:919-923